Bausch & Lomb (BLCO) Depreciation & Amortization (CF) (2021 - 2026)
Bausch & Lomb (BLCO) reported Depreciation & Amortization (CF) of $101.0 million for Q1 2026, down 4.72% on a YoY basis from $106.0 million in Q1 2025, and up 2.02% quarter-over-quarter from $99.0 million in Q4 2025.
Bausch & Lomb (BLCO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $101.0 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 4.72% year-over-year to $101.0 million; the trailing twelve-month figure through Mar 2026 stood at $416.0 million (down 3.7% YoY), and the FY2025 full-year result was $421.0 million, down 3.44% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $101.0 million, up from $99.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $116.0 million in Q4 2023, with the low at $82.0 million in Q3 2023.
- Historically, Depreciation & Amortization (CF) has averaged $101.1 million across 5 years, with a median of $101.0 million in 2026.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) dropped 11.83% — and 2024, when it surged 34.15%.
- Bausch & Lomb's Depreciation & Amortization (CF) stood at $93.0 million in 2022, then climbed by 24.73% to $116.0 million in 2023, then declined by 8.62% to $106.0 million in 2024, then dropped by 6.6% to $99.0 million in 2025, then climbed by 2.02% to $101.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $101.0 million (Q1 2026), $99.0 million (Q4 2025), and $109.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 101.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.00 Mn |
| Mar 31, 2026 | 101.00 Mn |
| Dec 31, 2025 | 99.00 Mn |
| Dec 31, 2025 | 99.00 Mn |
| Sep 30, 2025 | 109.00 Mn |
| Sep 30, 2025 | 109.00 Mn |
| Jun 30, 2025 | 107.00 Mn |
| Jun 30, 2025 | 107.00 Mn |
| Mar 31, 2025 | 106.00 Mn |
| Mar 31, 2025 | 106.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Sep 30, 2024 | 110.00 Mn |
| Sep 30, 2024 | 110.00 Mn |
| Jun 30, 2024 | 110.00 Mn |
| Jun 30, 2024 | 110.00 Mn |
| Mar 31, 2024 | 110.00 Mn |
| Mar 31, 2024 | 110.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Dec 31, 2023 | 116.00 Mn |